Article
Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.
Stem cells translational medicine - 1 Oct 2012
Chase Lucas G, Yang Sufang, Zachar Vladimir, Yang Zheng, Lakshmipathy Uma, Bradford Jolene, Boucher Shayne E, Vemuri Mohan C
Abstract excerpt
Human multipotent mesenchymal stem cell (MSC) therapies are currently being tested in clinical trials for Crohn's disease, multiple sclerosis, graft-versus-host disease, type 1 diabetes, bone fractures, cartilage damage, and cardiac diseases. Despite remarkable progress in clinical trials, most applications still use traditional culture media containing fetal bovine serum or serum-free media that contain serum...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
